193. プラダー・ウィリ症候群 Prader-Willi syndrome Clinical trials / Disease details

臨床試験数 : 111 / 薬物数 : 120 - (DrugBank : 30) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 103

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR1900027464	2019-12-01	2019-11-14	Efficacy and safety of anastrozolecombined with growth hormone in the treatment of Prader Willi synd ...	Efficacy and safety of anastrozolecombined with growth hormone in the treatment of Prader Willi synd ...	Prader-Willi syndrome	control group:Single rhGH therapy;observation group:Anastrazole combined with growth hormone therapy;	Children's Hospital of Zhejiang University School of Medicine	NULL	Pending			Male	control group:20;observation group:20;	Phase 4	China
2	NCT01520467 (ClinicalTrials.gov)	April 2012	25/1/2012	Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi Syndrome	Efficacy and Tolerance of Treatment With an Aromatase Inhibitor (Anastrozole) to Limit the Progressi ...	Silver Russell Syndrome;Prader-Willi Syndrome	Drug: Anastrozole;Drug: Placebo	Assistance Publique - Hôpitaux de Paris	NULL	Active, not recruiting	5 Years	12 Years	Both	27	N/A	France

First Previous1Next Last